Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.43 |
| ▸ | DAO | P14920 | 1/20 | 0.43 |
| ▸ | GSK3B | P49841 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.35 |
| ▸ | HPGD | P15428 | 3/20 | 0.35 |
| ▸ | PPARA | Q07869 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | CASP3 | P42574 | 1/20 | 0.33 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.33 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.33 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.33 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8672684 | 0.86 | ALDH1A1 (0.32) | F2DAOALDH1A1 | |
| SCHEMBL486042 | 0.83 | DAO (0.48) | F2DAOGSK3BTSHRALDH1A1 | |
| SCHEMBL7003234 | 0.81 | F2 (0.42) | F2DAOGSK3BTSHRALDH1A1 | |
| SCHEMBL8189892 | 0.78 | POLB (0.40) | F2DAOGSK3BTSHRALDH1A1 | |
| SCHEMBL4769604 | 0.77 | DAO (0.42) | DAOALDH1A1HPGDKDM4EGAA | |
| SCHEMBL9817948 | 0.77 | CES2 (0.43) | DAOGSK3BALDH1A1HPGDKDM4E | |
| SCHEMBL25246892 | 0.76 | F2 (0.38) | F2DAOGSK3BTSHRALDH1A1 | |
| SCHEMBL4070283 | 0.69 | KMT2A (0.47) | F2DAOGSK3BALDH1A1HPGD | |
| SCHEMBL13624441 | 0.68 | GSK3B (0.39) | F2DAOGSK3BALDH1A1HPGD | |
| SCHEMBL9218012 | 0.68 | DAO (0.45) | DAOGSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2099453-B1 | Combination therapy of substituted oxazolidinones | BAYER IP GMBH (DE) | 2017-09-06 | — | — | EP | disclosed |
| EP-1526132-B1 | Substituted oxazolidinone derivatives and their use as factor xa inhibitors | BAYER IP GMBH (DE) | 2014-03-12 | — | — | EP | disclosed |
| EP-1928867-B1 | 2-AMINOETHOXYACETIC ACID DERIVATIVES AND THEIR USE IN TREATING THROMBOEMBOLIC DISORDERS | BAYER IP GMBH (DE) | 2013-05-22 | — | — | EP | disclosed |
| EP-2132193-B1 | SUBSTITUTED PYRROLIDINE AMIDES, THE PRODUCTION THEREOF, AND THE USE THEREOF AS MEDICATIONS | BOEHRINGER INGELHEIM INT (DE) | 2012-10-24 | — | — | EP | disclosed |
| EP-2388260-A1 | Method for producing a blood coagulation factor inhibitor | Archimica GmbH (DE) | 2011-11-23 | — | — | EP | disclosed |
| EP-1899330-B9 | SUBSTITUTED GLYCINAMIDES HAVING AN ANTITHROMBOTIC AND FACTOR XA-INHIBITING EFFECT | BOEHRINGER INGELHEIM INT (DE) | 2011-11-09 | — | — | EP | disclosed |
| US-8038533-B2 | Game system using parent game machine and child game machine | NINTENDO CO., LTD. (JP) | 2011-10-18 | — | — | US | disclosed |
| EP-1945634-B1 | PHENYLENEBISOXAZOLIDINE DERIVATIVES AND THEIR USE AS ANTICOAGULANTS | BAYER SCHERING PHARMA AG (DE) | 2011-01-19 | — | — | EP | disclosed |
| EP-1899330-B1 | SUBSTITUTED GLYCINAMIDES HAVING AN ANTITHROMBOTIC AND FACTOR XA-INHIBITING EFFECT | BOEHRINGER INGELHEIM INT (DE) | 2010-11-24 | — | — | EP | disclosed |
| EP-1874764-B1 | IMINO-OXAZOLIDINES AND USE THEREOF AS ANTICOAGULANTS | BAYER SCHERING PHARMA AG (DE) | 2010-11-10 | — | — | EP | disclosed |
| WO-2003007942-A1 | SUBSTITUTED ISOINDOLES AND THE USE THEREOF | BAYER HEALTHCARE AG (DE) | 2003-01-30 | — | — | WO | disclosed |
| WO-2003000256-A1 | SUBSTITUTED OXAZOLIDINONES FOR COMBINATIONAL THERAPY | BAYER HEALTHCARE AG (DE) | 2003-01-03 | — | — | WO | disclosed |
| WO-2001047919-A9 | SUBSTITUTED OXAZOLIDINONES AND THEIR USE IN THE FIELD OF BLOOD COAGULATION | BAYER AG (DE) | 2002-12-19 | — | — | WO | disclosed |
| EP-1261606-A1 | SUBSTITUTED OXAZOLIDINONES AND THEIR USE IN THE FIELD OF BLOOD COAGULATION | Bayer Aktiengesellschaft (DE) | 2002-12-04 | — | — | EP | disclosed |
| EP-1252163-A2 | 4-PYRIDYL-AND 2,4-PYRIMIDINYL-SUBSTITUTED PYRROLE DERIVATIVES AND THEIR USE IN PHARMACY | MERCKLE GMBH (DE) | 2002-10-30 | — | — | EP | disclosed |
| WO-2001057042-A2 | 4-PYRIDYL-AND 2,4-PYRIMIDINYL-SUBSTITUTED PYRROLE DERIVATIVES AND THEIR USE IN PHARMACY | MERCKLE GMBH (DE) | 2001-08-09 | — | — | WO | disclosed |
| WO-2001047919-A1 | SUBSTITUTED OXAZOLIDINONES AND THEIR USE IN THE FIELD OF BLOOD COAGULATION | BAYER AKTIENGESELLSCHAFT (DE) | 2001-07-05 | — | — | WO | disclosed |
| EP-0109381-B1 | THIOPHENE-2-CARBOXYLIC-ACID DERIVATIVES AND PROCESS FOR THEIR PREPARATION | Laevosan-Gesellschaft m.b.H. (AT) | 1986-07-30 | — | — | EP | disclosed |
| EP-0126225-A1 | Process for the preparation of substituted trialkylsilyloxymalonic-acid dinitriles | BAYER AG (DE) | 1984-11-28 | — | — | EP | disclosed |
| EP-0109381-A1 | Thiophene-2-carboxylic-acid derivatives and process for their preparation | Laevosan-Gesellschaft m.b.H. (AT) | 1984-05-23 | — | — | EP | disclosed |